Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dova Pharmaceuticals Inc. (DOVA) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dova Pharmaceuticals Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1685071.
Total stock buying since 2017: $31,488,776.
Total stock sales since 2017: $876,860.
Total stock option exercises since 2017: $283,513.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2019 | 678,916 | $9,177,359 | 46,405 | $876,860 | 11,751 | $89,586 |
| 2018 | 962,031 | $16,384,987 | 0 | $0 | 12,832 | $93,930 |
| 2017 | 329,239 | $5,926,430 | 0 | $0 | 26,809 | $99,997 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2019-10 | 0 | $0 | 5,275 | $147,172 | 0 | $0 |
| 2019-09 | 0 | $0 | 10,936 | $281,408 | 0 | $0 |
| 2019-08 | 28,062 | $445,343 | 0 | $0 | 0 | $0 |
| 2019-07 | 155,645 | $2,540,615 | 25,420 | $393,727 | 0 | $0 |
| 2019-06 | 427,209 | $5,682,761 | 2,387 | $33,620 | 3,500 | $29,190 |
| 2019-05 | 0 | $0 | 0 | $0 | 3,668 | $26,849 |
| 2019-04 | 0 | $0 | 2,387 | $20,933 | 0 | $0 |
| 2019-03 | 68,000 | $508,640 | 0 | $0 | 0 | $0 |
| 2019-01 | 0 | $0 | 0 | $0 | 4,583 | $33,547 |
| 2018-12 | 468,631 | $2,972,152 | 0 | $0 | 0 | $0 |
| 2018-08 | 21,700 | $495,410 | 0 | $0 | 1,832 | $13,410 |
| 2018-06 | 471,700 | $12,917,425 | 0 | $0 | 11,000 | $80,520 |
| 2017-12 | 0 | $0 | 0 | $0 | 26,809 | $99,997 |
| 2017-08 | 46,039 | $1,031,030 | 0 | $0 | 0 | $0 |
| 2017-07 | 283,200 | $4,895,400 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-10-01 | Zaccardelli David (President & CEO) | Sale | 5,275 | 27.90 | 147,172 |
| 2019-09-30 | Hoitt Jason (Chief Commercial Officer) | Sale | 2,387 | 28.00 | 66,836 |
| 2019-09-30 | Laliberte Kevin (Sr. VP, Product Development) | Sale | 3,696 | 28.00 | 103,488 |
| 2019-09-30 | Hahn Mark W (Chief Financial Officer) | Sale | 775 | 28.00 | 21,700 |
| 2019-09-30 | Allen Lee F Md Phd (Chief Medical Officer) | Sale | 978 | 28.00 | 27,384 |
| 2019-09-25 | Laliberte Kevin (Sr. VP, Product Development) | Sale | 3,100 | 20.00 | 62,000 |
| 2019-08-09 | Manning Paul B (Director) | Buy | 28,062 | 15.87 | 445,343 |
| 2019-07-31 | Laliberte Kevin (Sr. VP, Product Development) | Sale | 1,389 | 15.97 | 22,182 |
| 2019-07-15 | Hoitt Jason (Chief Commercial Officer) | Sale | 7,580 | 15.77 | 119,536 |
| 2019-07-11 | Edelman Joseph (10% Owner) | Buy | 42,916 | 16.67 | 715,409 |
| 2019-07-10 | Edelman Joseph (10% Owner) | Buy | 12,354 | 16.89 | 208,659 |
| 2019-07-09 | Edelman Joseph (10% Owner) | Buy | 29,834 | 16.61 | 495,542 |
| 2019-07-05 | Edelman Joseph (10% Owner) | Buy | 50,000 | 16.46 | 823,000 |
| 2019-07-03 | Edelman Joseph (10% Owner) | Buy | 1,705 | 16.67 | 28,422 |
| 2019-07-02 | Zaccardelli David (President & CEO) | Sale | 10,450 | 15.97 | 166,938 |
| 2019-07-02 | Edelman Joseph (10% Owner) | Buy | 715 | 16.14 | 11,540 |
| 2019-07-01 | Laliberte Kevin (Sr. VP, Product Development) | Sale | 1,191 | 14.17 | 16,876 |
| 2019-07-01 | Hahn Mark W (Chief Financial Officer) | Sale | 1,545 | 14.17 | 21,892 |
| 2019-07-01 | Allen Lee F Md Phd (Chief Medical Officer) | Sale | 1,957 | 14.19 | 27,769 |
| 2019-07-01 | Jeffs Roger (Director) | Sale | 1,308 | 14.17 | 18,534 |
| 2019-07-01 | Edelman Joseph (10% Owner) | Buy | 18,121 | 14.24 | 258,043 |
| 2019-06-28 | Hoitt Jason (Chief Commercial Officer) | Sale | 2,387 | 14.09 | 33,620 |
| 2019-06-28 | Edelman Joseph (10% Owner) | Buy | 100,000 | 14.22 | 1,422,500 |
| 2019-06-27 | Edelman Joseph (10% Owner) | Buy | 327,209 | 13.02 | 4,260,261 |
| 2019-06-26 | Goldman Steven M. (Director) | Option Ex | 1,750 | 8.34 | 14,595 |
| 2019-06-20 | Goldman Steven M. (Director) | Option Ex | 1,750 | 8.34 | 14,595 |
| 2019-05-13 | Goldman Steven M. (Director) | Option Ex | 3,668 | 7.32 | 26,849 |
| 2019-04-08 | Hoitt Jason (Chief Commercial Officer) | Sale | 2,387 | 8.77 | 20,933 |
| 2019-03-07 | Manning Paul B (Director) | Buy | 68,000 | 7.48 | 508,640 |
| 2019-01-02 | Goldman Steven M. (Director) | Option Ex | 4,583 | 7.32 | 33,547 |
| 2018-12-21 | Manning Paul B (Director) | Buy | 128,500 | 6.77 | 869,945 |
| 2018-12-20 | Stalfort Sean (Director) | Buy | 31,000 | 6.26 | 194,060 |
| 2018-12-20 | Zaccardelli David (President & CEO) | Buy | 10,000 | 6.07 | 60,700 |
| 2018-12-20 | Manning Paul B (Director) | Buy | 266,631 | 6.17 | 1,645,113 |
| 2018-12-20 | Jeffs Roger (Director) | Buy | 1,169 | 6.25 | 7,306 |
| 2018-12-19 | Hahn Mark W (Chief Financial Officer) | Buy | 2,500 | 6.28 | 15,700 |
| 2018-12-19 | Jeffs Roger (Director) | Buy | 28,831 | 6.22 | 179,328 |
| 2018-08-14 | Sapir Alex (President & CEO) | Buy | 21,700 | 22.83 | 495,410 |
| 2018-08-13 | Goldman Steven M. (Director) | Option Ex | 1,832 | 7.32 | 13,410 |
| 2018-06-21 | Goldman Steven M. (Director) | Buy | 5,000 | 30.22 | 151,100 |
| 2018-06-11 | Edelman Joseph (10% Owner) | Buy | 19,700 | 29.50 | 581,150 |
| 2018-06-08 | Edelman Joseph (10% Owner) | Buy | 25,000 | 28.80 | 719,875 |
| 2018-06-07 | Manning Paul B (Director) | Buy | 10,000 | 27.77 | 277,750 |
| 2018-06-07 | Edelman Joseph (10% Owner) | Buy | 50,000 | 28.40 | 1,419,850 |
| 2018-06-06 | Goldman Steven M. (Director) | Option Ex | 11,000 | 7.32 | 80,520 |
| 2018-06-06 | Manning Paul B (Director) | Buy | 17,000 | 28.85 | 490,450 |
| 2018-06-06 | Edelman Joseph (10% Owner) | Buy | 100,000 | 28.64 | 2,864,500 |
| 2018-06-05 | Goldman Steven M. (Director) | Buy | 15,000 | 26.41 | 396,150 |
| 2018-06-05 | Manning Paul B (Director) | Buy | 100,000 | 26.48 | 2,648,500 |
| 2018-06-05 | Edelman Joseph (10% Owner) | Buy | 100,000 | 26.30 | 2,629,700 |
| 2018-06-04 | Manning Paul B (Director) | Buy | 20,000 | 24.39 | 487,700 |
| 2018-06-04 | Edelman Joseph (10% Owner) | Buy | 10,000 | 25.07 | 250,700 |
| 2017-12-22 | Sapir Alex (President & CEO) | Option Ex | 26,809 | 3.73 | 99,997 |
| 2017-08-16 | Pbm Capital Investments, Llc (10% Owner) | Buy | 5,000 | 25.77 | 128,835 |
| 2017-08-15 | Pbm Capital Investments, Llc (10% Owner) | Buy | 20,870 | 21.77 | 454,444 |
| 2017-08-15 | Goldman Steven M. (Director) | Buy | 20,169 | 22.20 | 447,751 |
| 2017-07-05 | Laliberte Kevin (Sr. VP, Product Development) | Buy | 6,200 | 17.00 | 105,400 |
| 2017-07-05 | Sapir Alex (President & CEO) | Buy | 20,100 | 17.00 | 341,700 |
| 2017-07-05 | Pbm Capital Investments, Llc (10% Owner) | Buy | 150,000 | 17.00 | 2,550,000 |
| 2017-07-05 | Goldman Steven M. (Director) | Buy | 72,000 | 18.12 | 1,305,000 |
| 2017-07-05 | Allen Lee F Md Phd (Chief Medical Officer) | Buy | 3,500 | 17.00 | 59,500 |
| 2017-07-05 | Jeffs Roger (Director) | Buy | 31,400 | 17.00 | 533,800 |
Insider trading activities including stock purchases, stock sales, and option exercises of DOVA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dova Pharmaceuticals Inc. (symbol DOVA, CIK number 1685071) see the Securities and Exchange Commission (SEC) website.